世界のC-X-Cケモカイン受容体タイプ4市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global C-X-C Chemokine Receptor Type 4 Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5685 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、C-X-Cケモカイン受容体タイプ4の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（AM-3114、BL-8040、GMI-1359、HPH-112、その他）、用途別市場規模（肝がん、心筋梗塞、腎細胞がん、脳卒中、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・C-X-Cケモカイン受容体タイプ4の市場動向 ・企業の競争状況、市場シェア ・C-X-Cケモカイン受容体タイプ4の種類別市場規模と予測2016-2027（AM-3114、BL-8040、GMI-1359、HPH-112、その他） ・C-X-Cケモカイン受容体タイプ4の用途別市場規模と予測2016-2027（肝がん、心筋梗塞、腎細胞がん、脳卒中、その他） ・C-X-Cケモカイン受容体タイプ4の北米市場規模2016-2027（アメリカ、カナダ） ・C-X-Cケモカイン受容体タイプ4の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・C-X-Cケモカイン受容体タイプ4のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・C-X-Cケモカイン受容体タイプ4の中南米市場規模2016-2027（メキシコ、ブラジル） ・C-X-Cケモカイン受容体タイプ4の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AdAlta Pty Ltd.、Ambrx, Inc.、Anchor Therapeutics, Inc.、Biokine Therapeutics Ltd.、BioLineRx, Ltd.、Bristol-Myers Squibb Company、Eli Lilly and Company、Globavir Biosciences, Inc.、GlycoMimetics, Inc.、NeED Pharma s.r.l.、Pharis Biotec GmbH、Polyphor Ltd.、Sanofi、TaiGen Biotechnology Co., Ltd.、Upsher-Smith Laboratories, Inc.、X4 Pharmaceuticals, Inc.） ・結論

Market Analysis and Insights: Global C-X-C Chemokine Receptor Type 4 Market
The global C-X-C Chemokine Receptor Type 4 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global C-X-C Chemokine Receptor Type 4 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global C-X-C Chemokine Receptor Type 4 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global C-X-C Chemokine Receptor Type 4 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global C-X-C Chemokine Receptor Type 4 market.

Global C-X-C Chemokine Receptor Type 4 Scope and Market Size
C-X-C Chemokine Receptor Type 4 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global C-X-C Chemokine Receptor Type 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
AM-3114
BL-8040
GMI-1359
HPH-112
Others

Segment by Application
Liver Cancer
Myocardial Infarction
Renal Cell Carcinoma
Stroke
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AdAlta Pty Ltd.
Ambrx, Inc.
Anchor Therapeutics, Inc.
Biokine Therapeutics Ltd.
BioLineRx, Ltd.
Bristol-Myers Squibb Company
Eli Lilly and Company
Globavir Biosciences, Inc.
GlycoMimetics, Inc.
NeED Pharma s.r.l.
Pharis Biotec GmbH
Polyphor Ltd.
Sanofi
TaiGen Biotechnology Co., Ltd.
Upsher-Smith Laboratories, Inc.
X4 Pharmaceuticals, Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global C-X-C Chemokine Receptor Type 4 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 AM-3114
1.2.3 BL-8040
1.2.4 GMI-1359
1.2.5 HPH-112
1.2.6 Others
1.3 Market by Application
1.3.1 Global C-X-C Chemokine Receptor Type 4 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Liver Cancer
1.3.3 Myocardial Infarction
1.3.4 Renal Cell Carcinoma
1.3.5 Stroke
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global C-X-C Chemokine Receptor Type 4 Market Perspective (2016-2027)
2.2 C-X-C Chemokine Receptor Type 4 Growth Trends by Regions
2.2.1 C-X-C Chemokine Receptor Type 4 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 C-X-C Chemokine Receptor Type 4 Historic Market Share by Regions (2016-2021)
2.2.3 C-X-C Chemokine Receptor Type 4 Forecasted Market Size by Regions (2022-2027)
2.3 C-X-C Chemokine Receptor Type 4 Industry Dynamic
2.3.1 C-X-C Chemokine Receptor Type 4 Market Trends
2.3.2 C-X-C Chemokine Receptor Type 4 Market Drivers
2.3.3 C-X-C Chemokine Receptor Type 4 Market Challenges
2.3.4 C-X-C Chemokine Receptor Type 4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top C-X-C Chemokine Receptor Type 4 Players by Revenue
3.1.1 Global Top C-X-C Chemokine Receptor Type 4 Players by Revenue (2016-2021)
3.1.2 Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Players (2016-2021)
3.2 Global C-X-C Chemokine Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by C-X-C Chemokine Receptor Type 4 Revenue
3.4 Global C-X-C Chemokine Receptor Type 4 Market Concentration Ratio
3.4.1 Global C-X-C Chemokine Receptor Type 4 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by C-X-C Chemokine Receptor Type 4 Revenue in 2020
3.5 C-X-C Chemokine Receptor Type 4 Key Players Head office and Area Served
3.6 Key Players C-X-C Chemokine Receptor Type 4 Product Solution and Service
3.7 Date of Enter into C-X-C Chemokine Receptor Type 4 Market
3.8 Mergers & Acquisitions, Expansion Plans

4 C-X-C Chemokine Receptor Type 4 Breakdown Data by Type
4.1 Global C-X-C Chemokine Receptor Type 4 Historic Market Size by Type (2016-2021)
4.2 Global C-X-C Chemokine Receptor Type 4 Forecasted Market Size by Type (2022-2027)

5 C-X-C Chemokine Receptor Type 4 Breakdown Data by Application
5.1 Global C-X-C Chemokine Receptor Type 4 Historic Market Size by Application (2016-2021)
5.2 Global C-X-C Chemokine Receptor Type 4 Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America C-X-C Chemokine Receptor Type 4 Market Size (2016-2027)
6.2 North America C-X-C Chemokine Receptor Type 4 Market Size by Type
6.2.1 North America C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2021)
6.2.2 North America C-X-C Chemokine Receptor Type 4 Market Size by Type (2022-2027)
6.2.3 North America C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2027)
6.3 North America C-X-C Chemokine Receptor Type 4 Market Size by Application
6.3.1 North America C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2021)
6.3.2 North America C-X-C Chemokine Receptor Type 4 Market Size by Application (2022-2027)
6.3.3 North America C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2027)
6.4 North America C-X-C Chemokine Receptor Type 4 Market Size by Country
6.4.1 North America C-X-C Chemokine Receptor Type 4 Market Size by Country (2016-2021)
6.4.2 North America C-X-C Chemokine Receptor Type 4 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe C-X-C Chemokine Receptor Type 4 Market Size (2016-2027)
7.2 Europe C-X-C Chemokine Receptor Type 4 Market Size by Type
7.2.1 Europe C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2021)
7.2.2 Europe C-X-C Chemokine Receptor Type 4 Market Size by Type (2022-2027)
7.2.3 Europe C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2027)
7.3 Europe C-X-C Chemokine Receptor Type 4 Market Size by Application
7.3.1 Europe C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2021)
7.3.2 Europe C-X-C Chemokine Receptor Type 4 Market Size by Application (2022-2027)
7.3.3 Europe C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2027)
7.4 Europe C-X-C Chemokine Receptor Type 4 Market Size by Country
7.4.1 Europe C-X-C Chemokine Receptor Type 4 Market Size by Country (2016-2021)
7.4.2 Europe C-X-C Chemokine Receptor Type 4 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size (2016-2027)
8.2 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Type
8.2.1 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2027)
8.3 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Application
8.3.1 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2027)
8.4 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Region
8.4.1 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America C-X-C Chemokine Receptor Type 4 Market Size (2016-2027)
9.2 Latin America C-X-C Chemokine Receptor Type 4 Market Size by Type
9.2.1 Latin America C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2021)
9.2.2 Latin America C-X-C Chemokine Receptor Type 4 Market Size by Type (2022-2027)
9.2.3 Latin America C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2027)
9.3 Latin America C-X-C Chemokine Receptor Type 4 Market Size by Application
9.3.1 Latin America C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2021)
9.3.2 Latin America C-X-C Chemokine Receptor Type 4 Market Size by Application (2022-2027)
9.3.3 Latin America C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2027)
9.4 Latin America C-X-C Chemokine Receptor Type 4 Market Size by Country
9.4.1 Latin America C-X-C Chemokine Receptor Type 4 Market Size by Country (2016-2021)
9.4.2 Latin America C-X-C Chemokine Receptor Type 4 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size (2016-2027)
10.2 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Type
10.2.1 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2027)
10.3 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Application
10.3.1 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2027)
10.4 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Country
10.4.1 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AdAlta Pty Ltd.
11.1.1 AdAlta Pty Ltd. Company Details
11.1.2 AdAlta Pty Ltd. Business Overview
11.1.3 AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Introduction
11.1.4 AdAlta Pty Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.1.5 AdAlta Pty Ltd. Recent Development
11.2 Ambrx, Inc.
11.2.1 Ambrx, Inc. Company Details
11.2.2 Ambrx, Inc. Business Overview
11.2.3 Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Introduction
11.2.4 Ambrx, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.2.5 Ambrx, Inc. Recent Development
11.3 Anchor Therapeutics, Inc.
11.3.1 Anchor Therapeutics, Inc. Company Details
11.3.2 Anchor Therapeutics, Inc. Business Overview
11.3.3 Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Introduction
11.3.4 Anchor Therapeutics, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.3.5 Anchor Therapeutics, Inc. Recent Development
11.4 Biokine Therapeutics Ltd.
11.4.1 Biokine Therapeutics Ltd. Company Details
11.4.2 Biokine Therapeutics Ltd. Business Overview
11.4.3 Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Introduction
11.4.4 Biokine Therapeutics Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.4.5 Biokine Therapeutics Ltd. Recent Development
11.5 BioLineRx, Ltd.
11.5.1 BioLineRx, Ltd. Company Details
11.5.2 BioLineRx, Ltd. Business Overview
11.5.3 BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Introduction
11.5.4 BioLineRx, Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.5.5 BioLineRx, Ltd. Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Details
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Introduction
11.7.4 Eli Lilly and Company Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.7.5 Eli Lilly and Company Recent Development
11.8 Globavir Biosciences, Inc.
11.8.1 Globavir Biosciences, Inc. Company Details
11.8.2 Globavir Biosciences, Inc. Business Overview
11.8.3 Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Introduction
11.8.4 Globavir Biosciences, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.8.5 Globavir Biosciences, Inc. Recent Development
11.9 GlycoMimetics, Inc.
11.9.1 GlycoMimetics, Inc. Company Details
11.9.2 GlycoMimetics, Inc. Business Overview
11.9.3 GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Introduction
11.9.4 GlycoMimetics, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.9.5 GlycoMimetics, Inc. Recent Development
11.10 NeED Pharma s.r.l.
11.10.1 NeED Pharma s.r.l. Company Details
11.10.2 NeED Pharma s.r.l. Business Overview
11.10.3 NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Introduction
11.10.4 NeED Pharma s.r.l. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.10.5 NeED Pharma s.r.l. Recent Development
11.11 Pharis Biotec GmbH
11.11.1 Pharis Biotec GmbH Company Details
11.11.2 Pharis Biotec GmbH Business Overview
11.11.3 Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Introduction
11.11.4 Pharis Biotec GmbH Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.11.5 Pharis Biotec GmbH Recent Development
11.12 Polyphor Ltd.
11.12.1 Polyphor Ltd. Company Details
11.12.2 Polyphor Ltd. Business Overview
11.12.3 Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Introduction
11.12.4 Polyphor Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.12.5 Polyphor Ltd. Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi C-X-C Chemokine Receptor Type 4 Introduction
11.13.4 Sanofi Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.13.5 Sanofi Recent Development
11.14 TaiGen Biotechnology Co., Ltd.
11.14.1 TaiGen Biotechnology Co., Ltd. Company Details
11.14.2 TaiGen Biotechnology Co., Ltd. Business Overview
11.14.3 TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Introduction
11.14.4 TaiGen Biotechnology Co., Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.14.5 TaiGen Biotechnology Co., Ltd. Recent Development
11.15 Upsher-Smith Laboratories, Inc.
11.15.1 Upsher-Smith Laboratories, Inc. Company Details
11.15.2 Upsher-Smith Laboratories, Inc. Business Overview
11.15.3 Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Introduction
11.15.4 Upsher-Smith Laboratories, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.15.5 Upsher-Smith Laboratories, Inc. Recent Development
11.16 X4 Pharmaceuticals, Inc.
11.16.1 X4 Pharmaceuticals, Inc. Company Details
11.16.2 X4 Pharmaceuticals, Inc. Business Overview
11.16.3 X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Introduction
11.16.4 X4 Pharmaceuticals, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
11.16.5 X4 Pharmaceuticals, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global C-X-C Chemokine Receptor Type 4 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of AM-3114
Table 3. Key Players of BL-8040
Table 4. Key Players of GMI-1359
Table 5. Key Players of HPH-112
Table 6. Key Players of Others
Table 7. Global C-X-C Chemokine Receptor Type 4 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global C-X-C Chemokine Receptor Type 4 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global C-X-C Chemokine Receptor Type 4 Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global C-X-C Chemokine Receptor Type 4 Market Share by Regions (2016-2021)
Table 11. Global C-X-C Chemokine Receptor Type 4 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global C-X-C Chemokine Receptor Type 4 Market Share by Regions (2022-2027)
Table 13. C-X-C Chemokine Receptor Type 4 Market Trends
Table 14. C-X-C Chemokine Receptor Type 4 Market Drivers
Table 15. C-X-C Chemokine Receptor Type 4 Market Challenges
Table 16. C-X-C Chemokine Receptor Type 4 Market Restraints
Table 17. Global C-X-C Chemokine Receptor Type 4 Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global C-X-C Chemokine Receptor Type 4 Market Share by Players (2016-2021)
Table 19. Global Top C-X-C Chemokine Receptor Type 4 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in C-X-C Chemokine Receptor Type 4 as of 2020)
Table 20. Ranking of Global Top C-X-C Chemokine Receptor Type 4 Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by C-X-C Chemokine Receptor Type 4 Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players C-X-C Chemokine Receptor Type 4 Product Solution and Service
Table 24. Date of Enter into C-X-C Chemokine Receptor Type 4 Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2021) (US$ Million)
Table 27. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Type (2016-2021)
Table 28. Global C-X-C Chemokine Receptor Type 4 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global C-X-C Chemokine Receptor Type 4 Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Application (2016-2021)
Table 32. Global C-X-C Chemokine Receptor Type 4 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2021) (US$ Million)
Table 35. North America C-X-C Chemokine Receptor Type 4 Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2021) (US$ Million)
Table 37. North America C-X-C Chemokine Receptor Type 4 Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America C-X-C Chemokine Receptor Type 4 Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America C-X-C Chemokine Receptor Type 4 Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe C-X-C Chemokine Receptor Type 4 Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe C-X-C Chemokine Receptor Type 4 Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe C-X-C Chemokine Receptor Type 4 Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe C-X-C Chemokine Receptor Type 4 Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America C-X-C Chemokine Receptor Type 4 Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America C-X-C Chemokine Receptor Type 4 Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America C-X-C Chemokine Receptor Type 4 Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America C-X-C Chemokine Receptor Type 4 Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Country (2022-2027) & (US$ Million)
Table 64. AdAlta Pty Ltd. Company Details
Table 65. AdAlta Pty Ltd. Business Overview
Table 66. AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Product
Table 67. AdAlta Pty Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 68. AdAlta Pty Ltd. Recent Development
Table 69. Ambrx, Inc. Company Details
Table 70. Ambrx, Inc. Business Overview
Table 71. Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 72. Ambrx, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 73. Ambrx, Inc. Recent Development
Table 74. Anchor Therapeutics, Inc. Company Details
Table 75. Anchor Therapeutics, Inc. Business Overview
Table 76. Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 77. Anchor Therapeutics, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 78. Anchor Therapeutics, Inc. Recent Development
Table 79. Biokine Therapeutics Ltd. Company Details
Table 80. Biokine Therapeutics Ltd. Business Overview
Table 81. Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Product
Table 82. Biokine Therapeutics Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 83. Biokine Therapeutics Ltd. Recent Development
Table 84. BioLineRx, Ltd. Company Details
Table 85. BioLineRx, Ltd. Business Overview
Table 86. BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Product
Table 87. BioLineRx, Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 88. BioLineRx, Ltd. Recent Development
Table 89. Bristol-Myers Squibb Company Company Details
Table 90. Bristol-Myers Squibb Company Business Overview
Table 91. Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Product
Table 92. Bristol-Myers Squibb Company Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 93. Bristol-Myers Squibb Company Recent Development
Table 94. Eli Lilly and Company Company Details
Table 95. Eli Lilly and Company Business Overview
Table 96. Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Product
Table 97. Eli Lilly and Company Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 98. Eli Lilly and Company Recent Development
Table 99. Globavir Biosciences, Inc. Company Details
Table 100. Globavir Biosciences, Inc. Business Overview
Table 101. Globavir Biosciences, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 102. Globavir Biosciences, Inc. Recent Development
Table 103. GlycoMimetics, Inc. Company Details
Table 104. GlycoMimetics, Inc. Business Overview
Table 105. GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 106. GlycoMimetics, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 107. GlycoMimetics, Inc. Recent Development
Table 108. NeED Pharma s.r.l. Company Details
Table 109. NeED Pharma s.r.l. Business Overview
Table 110. NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Product
Table 111. NeED Pharma s.r.l. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 112. NeED Pharma s.r.l. Recent Development
Table 113. Pharis Biotec GmbH Company Details
Table 114. Pharis Biotec GmbH Business Overview
Table 115. Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Product
Table 116. Pharis Biotec GmbH Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 117. Pharis Biotec GmbH Recent Development
Table 118. Polyphor Ltd. Company Details
Table 119. Polyphor Ltd. Business Overview
Table 120. Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Product
Table 121. Polyphor Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 122. Polyphor Ltd. Recent Development
Table 123. Sanofi Company Details
Table 124. Sanofi Business Overview
Table 125. Sanofi C-X-C Chemokine Receptor Type 4 Product
Table 126. Sanofi Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 127. Sanofi Recent Development
Table 128. TaiGen Biotechnology Co., Ltd. Company Details
Table 129. TaiGen Biotechnology Co., Ltd. Business Overview
Table 130. TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Product
Table 131. TaiGen Biotechnology Co., Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 132. TaiGen Biotechnology Co., Ltd. Recent Development
Table 133. Upsher-Smith Laboratories, Inc. Company Details
Table 134. Upsher-Smith Laboratories, Inc. Business Overview
Table 135. Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 136. Upsher-Smith Laboratories, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 137. Upsher-Smith Laboratories, Inc. Recent Development
Table 138. X4 Pharmaceuticals, Inc. Company Details
Table 139. X4 Pharmaceuticals, Inc. Business Overview
Table 140. X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 141. X4 Pharmaceuticals, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 142. X4 Pharmaceuticals, Inc. Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global C-X-C Chemokine Receptor Type 4 Market Share by Type: 2020 VS 2027
Figure 2. AM-3114 Features
Figure 3. BL-8040 Features
Figure 4. GMI-1359 Features
Figure 5. HPH-112 Features
Figure 6. Others Features
Figure 7. Global C-X-C Chemokine Receptor Type 4 Market Share by Application: 2020 VS 2027
Figure 8. Liver Cancer Case Studies
Figure 9. Myocardial Infarction Case Studies
Figure 10. Renal Cell Carcinoma Case Studies
Figure 11. Stroke Case Studies
Figure 12. Others Case Studies
Figure 13. C-X-C Chemokine Receptor Type 4 Report Years Considered
Figure 14. Global C-X-C Chemokine Receptor Type 4 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global C-X-C Chemokine Receptor Type 4 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global C-X-C Chemokine Receptor Type 4 Market Share by Regions: 2020 VS 2027
Figure 17. Global C-X-C Chemokine Receptor Type 4 Market Share by Regions (2022-2027)
Figure 18. Global C-X-C Chemokine Receptor Type 4 Market Share by Players in 2020
Figure 19. Global Top C-X-C Chemokine Receptor Type 4 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in C-X-C Chemokine Receptor Type 4 as of 2020
Figure 20. The Top 10 and 5 Players Market Share by C-X-C Chemokine Receptor Type 4 Revenue in 2020
Figure 21. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Type (2016-2021)
Figure 22. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Type (2022-2027)
Figure 23. North America C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America C-X-C Chemokine Receptor Type 4 Market Share by Type (2016-2027)
Figure 25. North America C-X-C Chemokine Receptor Type 4 Market Share by Application (2016-2027)
Figure 26. North America C-X-C Chemokine Receptor Type 4 Market Share by Country (2016-2027)
Figure 27. United States C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe C-X-C Chemokine Receptor Type 4 Market Share by Type (2016-2027)
Figure 31. Europe C-X-C Chemokine Receptor Type 4 Market Share by Application (2016-2027)
Figure 32. Europe C-X-C Chemokine Receptor Type 4 Market Share by Country (2016-2027)
Figure 33. Germany C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Share by Type (2016-2027)
Figure 41. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Share by Application (2016-2027)
Figure 42. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Share by Region (2016-2027)
Figure 43. China C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America C-X-C Chemokine Receptor Type 4 Market Share by Type (2016-2027)
Figure 51. Latin America C-X-C Chemokine Receptor Type 4 Market Share by Application (2016-2027)
Figure 52. Latin America C-X-C Chemokine Receptor Type 4 Market Share by Country (2016-2027)
Figure 53. Mexico C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Share by Type (2016-2027)
Figure 57. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Share by Application (2016-2027)
Figure 58. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Share by Country (2016-2027)
Figure 59. Turkey C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. AdAlta Pty Ltd. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 63. Ambrx, Inc. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 64. Anchor Therapeutics, Inc. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 65. Biokine Therapeutics Ltd. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 66. BioLineRx, Ltd. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 67. Bristol-Myers Squibb Company Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 68. Eli Lilly and Company Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 69. Globavir Biosciences, Inc. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 70. GlycoMimetics, Inc. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 71. NeED Pharma s.r.l. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 72. Pharis Biotec GmbH Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 73. Polyphor Ltd. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 74. Sanofi Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 75. TaiGen Biotechnology Co., Ltd. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 76. Upsher-Smith Laboratories, Inc. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 77. X4 Pharmaceuticals, Inc. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

---